2013-12-30 19:55:51 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to Pulsion Medical Systems SE (PUS) and produced a report, rating the company's attractiveness to long-term investors.
Ilhavo, Portugal - SADIF Investment Analytics, announces a new summary due diligence report covering Pulsion Medical Systems SE (PUS). The report uses SADIF's powerful StockMarks™ stock rating system and contains important analysis for any current or potential Pulsion Medical Systems SE investor.
Report Summary: Pulsion Medical Systems SE is an average quality company with a positive outlook. Pulsion Medical Systems SE has strong business growth and is run by efficient management. The trend in Pulsion Medical Systems SE fair value exchange rate against its closest rated-competitor, Eckert %26 Ziegler AG, has been appreciating over the past 2 weeks. When compared to its closest competitor, Pulsion Medical Systems SE shows similar overvaluation and is equally likely to underperform the market.
The report breaks
down the Total StockMark into its three components - business, management and price, performing an in-depth analysis of Pulsion Medical Systems SE for long-term investors.
The report has been distributed to Thomson Reuters. It is available in Investext and from multiple professional platforms including Thomson Research, Thomson ONE Banker, DIALOG/INTELLISCOPE, Thomson Gale, One source West Services, and Dow Jones/Factiva.
About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering 31 different markets and over 22,000 companies. The StockMarks rating system is based on proven investment principles and is designed to drive long-term shareholder returns.